Literature DB >> 16387706

Herbal complement inhibitors in the treatment of neuroinflammation: future strategy for neuroprotection.

Amod P Kulkarni1, Laurie A Kellaway, Girish J Kotwal.   

Abstract

The upregulated complement system plays a damaging role in disorders of the central nervous system (CNS). The classical and alternate pathways are two major pathways activated in neuroinflammatory disorders such as Alzheimer's disease, multiple sclerosis, traumatic brain injury, spinal cord injury, HIV-associated dementia, Parkinson's disease, and mad cow disease. Failure of currently available anti-inflammatory agents, especially cyclooxygenase inhibitors, in offering significant neuroprotection in large epidemiologic clinical trials of CNS disorders suggests an urgent need for the development of new neuroprotective agents. The positive preclinical outcomes in treating CNS disorders by complement regulatory molecules, such as vaccinia virus complement control protein, suggest the possibility of using complement-inhibitory molecules as neuroprotective agents. Several active ingredients of herbal origin are found to have complement-inhibitory activity. These herbal ingredients along with other anti-inflammatory roles might be useful in treating neuroinflammation associated with CNS disorders. Active ingredients of herbal origin with complement inhibitory ingredients are summarized and classified according to their chemical nature and specificity towards the major pathways activating the complement system. The structure activity relationship of some specific examples is also discussed in this report. This information might be helpful in formulating a natural panacea against complement-mediated neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16387706     DOI: 10.1196/annals.1352.020

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

2.  MS14, an Iranian herbal-marine compound for the treatment of multiple sclerosis.

Authors:  Amrollah Ahmadi; Gholameza Habibi; Mehdi Farrokhnia
Journal:  Chin J Integr Med       Date:  2010-08-08       Impact factor: 1.978

3.  Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease.

Authors:  Dmitri Leonoudakis; Anand Rane; Suzanne Angeli; Gordon J Lithgow; Julie K Andersen; Shankar J Chinta
Journal:  Mediators Inflamm       Date:  2017-04-04       Impact factor: 4.711

Review 4.  Complement activation and inhibition in wound healing.

Authors:  Gwendolyn Cazander; Gerrolt N Jukema; Peter H Nibbering
Journal:  Clin Dev Immunol       Date:  2012-12-30

5.  Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice.

Authors:  Iris Leinhase; Michal Rozanski; Denise Harhausen; Joshua M Thurman; Oliver I Schmidt; Amir M Hossini; Mohy E Taha; Daniel Rittirsch; Peter A Ward; V Michael Holers; Wolfgang Ertel; Philip F Stahel
Journal:  J Neuroinflammation       Date:  2007-05-02       Impact factor: 8.322

6.  Nootropic activity of Crataeva nurvala Buch-Ham against scopolamine induced cognitive impairment.

Authors:  Atanu Bhattacharjee; Shastry Chakrakodi Shashidhara; Santanu Saha
Journal:  EXCLI J       Date:  2015-02-27       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.